Home/Filings/4/0001251769-22-000053
4//SEC Filing

McKhann Chas 4

Accession 0001251769-22-000053

CIK 0001251769other

Filed

Jun 15, 8:00 PM ET

Accepted

Jun 16, 9:17 PM ET

Size

7.9 KB

Accession

0001251769-22-000053

Insider Transaction Report

Form 4
Period: 2022-06-14
McKhann Chas
DirectorPresident and CEO
Transactions
  • Award

    Common Stock

    2022-06-14+112,607689,880 total
  • Award

    Stock Option (Right to Buy)

    2022-06-14+459,170459,170 total
    Exercise: $3.95Exp: 2032-06-14Common Stock (459,170 underlying)
Footnotes (2)
  • [F1]Represents the grant of Restricted Stock Units ("RSUs"). Each RSU provides the Reporting Person with a contingent right to receive one share of the Issuer's common stock pursuant to the Issuer's 2017 Equity Incentive Plan (the "Plan"). The RSUs vest in equal annual installments over four years commencing on the grant date, subject to the Reporting Person providing continuous service to the Issuer through each such date. Accelerated vesting may occur in the event of a Change in Control, as that term is defined in the Plan.
  • [F2]The shares underlying the option shall vest as to 25% on the first anniversary of the grant date and the remainder will vest in equal monthly installments over the following three years, subject to the Reporting Person providing continuous service to the Issuer through each such date. Accelerated vesting may occur in the event of a Change in Control, as that term is defined in the Apollo Endosurgery, Inc. 2017 Equity Incentive Plan.

Issuer

Apollo Endosurgery, Inc.

CIK 0001251769

Entity typeother

Related Parties

1
  • filerCIK 0001631746

Filing Metadata

Form type
4
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 9:17 PM ET
Size
7.9 KB